Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Construction is expected to start in the second half of 2026, with commercialization in 2028, says Unibio CEO David Henstrom.

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest ...

Scientists from the National University of Singapore (NUS) have developed a biochemical technique that captures fleeting ...

Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of ...

Emerging technologies such as lab-based meat could produce the same quality and quantity of protein on hundreds of times less land.

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...

Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as a universal immunotherapy for cancers that form solid tumors, including ...

The very first patient would receive the first clinical doses of HMBD-001, the first cancer treatment from Hummingbird Bioscience. Piers Ingram, the cofounder and CEO of the company, was nervous, but ...

Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...

Researchers from the Photovoltaics and Thin-Film Electronics Laboratory (PV-Lab) in EPFL's School of Engineering and CSEM ...

Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness -CUE-401 is the Company's lead asset for the treatment of autoimmune and inflammatory diseasesAppointed indust ...